Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Of fish and men: clonal lineage analysis identifies divergence in myocardial development.

Circulation research

Sharma A, Wu SM.
PMID: 23410876
Circ Res. 2013 Feb 15;112(4):583-5. doi: 10.1161/CIRCRESAHA.113.300964.

No abstract available.

Cite
Sharma A, Wu SM. Of fish and men: clonal lineage analysis identifies divergence in myocardial development. Circ Res. 2013;112(4):583-5doi: 10.1161/CIRCRESAHA.113.300964.
Sharma, A., & Wu, S. M. (2013). Of fish and men: clonal lineage analysis identifies divergence in myocardial development. Circulation research, 112(4), 583-5. https://doi.org/10.1161/CIRCRESAHA.113.300964
Sharma, Arun, and Wu, Sean M. "Of fish and men: clonal lineage analysis identifies divergence in myocardial development." Circulation research vol. 112,4 (2013): 583-5. doi: https://doi.org/10.1161/CIRCRESAHA.113.300964
Sharma A, Wu SM. Of fish and men: clonal lineage analysis identifies divergence in myocardial development. Circ Res. 2013 Feb 15;112(4):583-5. doi: 10.1161/CIRCRESAHA.113.300964. PMID: 23410876; PMCID: PMC3600367.
Copy Download .nbib Format: NLM
Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes.

STAR protocols

Maas RGC, Lee S, Harakalova M, Snijders Blok CJB, Goodyer WR, Hjortnaes J, Doevendans PAFM, Van Laake LW, van der Velden J, Asselbergs FW, Wu JC, Sluijter JPG, Wu SM, Buikema JW.
PMID: 33615277
STAR Protoc. 2021 Feb 09;2(1):100334. doi: 10.1016/j.xpro.2021.100334. eCollection 2021 Mar 19.

Since the discovery of human induced pluripotent stem cells (hiPSCs), numerous strategies have been established to efficiently derive cardiomyocytes from hiPSCs (hiPSC-CMs). Here, we describe a cost-effective strategy for the subsequent massive expansion (>250-fold) of high-purity hiPSC-CMs relying on...

Cite
Maas RGC, Lee S, Harakalova M, et al. Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes. STAR Protoc. 2021;2(1):100334doi: 10.1016/j.xpro.2021.100334.
Maas, R. G. C., Lee, S., Harakalova, M., Snijders Blok, C. J. B., Goodyer, W. R., Hjortnaes, J., Doevendans, P. A. F. M., Van Laake, L. W., van der Velden, J., Asselbergs, F. W., Wu, J. C., Sluijter, J. P. G., Wu, S. M., & Buikema, J. W. (2021). Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes. STAR protocols, 2(1), 100334. https://doi.org/10.1016/j.xpro.2021.100334
Maas, Renee G C, et al. "Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes." STAR protocols vol. 2,1 (2021): 100334. doi: https://doi.org/10.1016/j.xpro.2021.100334
Maas RGC, Lee S, Harakalova M, Snijders Blok CJB, Goodyer WR, Hjortnaes J, Doevendans PAFM, Van Laake LW, van der Velden J, Asselbergs FW, Wu JC, Sluijter JPG, Wu SM, Buikema JW. Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes. STAR Protoc. 2021 Feb 09;2(1):100334. doi: 10.1016/j.xpro.2021.100334. eCollection 2021 Mar 19. PMID: 33615277; PMCID: PMC7881265.
Copy Download .nbib Format: NLM
Promises and pitfalls in cell replacement therapy for heart failure.

Drug discovery today. Disease mechanisms

Krane M, Wernet O, Wu SM.
PMID: 21180399
Drug Discov Today Dis Mech. 2010;7(2):e109-e115. doi: 10.1016/j.ddmec.2010.07.004.

Symptomatic heart failure is a complex clinical syndrome with a poor prognosis. Many efforts have been made to develop new therapeutic strategies to improve prognosis associated with heart failure. In this context, different stem cell populations for cardiac regenerative...

Cite
Krane M, Wernet O, Wu SM. Promises and pitfalls in cell replacement therapy for heart failure. Drug Discov Today Dis Mech. 2010;7(2):e109-e115doi: 10.1016/j.ddmec.2010.07.004.
Krane, M., Wernet, O., & Wu, S. M. (2010). Promises and pitfalls in cell replacement therapy for heart failure. Drug discovery today. Disease mechanisms, 7(2), e109-e115. https://doi.org/10.1016/j.ddmec.2010.07.004
Krane, Markus, et al. "Promises and pitfalls in cell replacement therapy for heart failure." Drug discovery today. Disease mechanisms vol. 7,2 (2010): e109-e115. doi: https://doi.org/10.1016/j.ddmec.2010.07.004
Krane M, Wernet O, Wu SM. Promises and pitfalls in cell replacement therapy for heart failure. Drug Discov Today Dis Mech. 2010;7(2):e109-e115. doi: 10.1016/j.ddmec.2010.07.004. PMID: 21180399; PMCID: PMC3003923.
Copy Download .nbib Format: NLM
Induced pluripotent stem cell modeling of complex genetic diseases.

Drug discovery today. Disease models

Hinson JT, Nakamura K, Wu SM.
PMID: 23690830
Drug Discov Today Dis Models. 2012;9(4):e147-e152. doi: 10.1016/j.ddmod.2012.04.002.

The study of complex disease genetics by genome-wide association studies (GWAS) has led to hundreds of genomic loci associated with disease traits in humans. However, the functional consequences of most loci are largely undefined. We discuss here the potential...

Cite
Hinson JT, Nakamura K, Wu SM. Induced pluripotent stem cell modeling of complex genetic diseases. Drug Discov Today Dis Models. 2012;9(4):e147-e152doi: 10.1016/j.ddmod.2012.04.002.
Hinson, J. T., Nakamura, K., & Wu, S. M. (2012). Induced pluripotent stem cell modeling of complex genetic diseases. Drug discovery today. Disease models, 9(4), e147-e152. https://doi.org/10.1016/j.ddmod.2012.04.002
Hinson, J Travis, et al. "Induced pluripotent stem cell modeling of complex genetic diseases." Drug discovery today. Disease models vol. 9,4 (2012): e147-e152. doi: https://doi.org/10.1016/j.ddmod.2012.04.002
Hinson JT, Nakamura K, Wu SM. Induced pluripotent stem cell modeling of complex genetic diseases. Drug Discov Today Dis Models. 2012;9(4):e147-e152. doi: 10.1016/j.ddmod.2012.04.002. PMID: 23690830; PMCID: PMC3653342.
Copy Download .nbib Format: NLM
Somatic Cell Reprogramming into Cardiovascular Lineages.

Journal of cardiovascular pharmacology and therapeutics

Chen JX, Plonowska K, Wu SM.
PMID: 24764131
J Cardiovasc Pharmacol Ther. 2014 Jul;19(4):340-349. doi: 10.1177/1074248414527641. Epub 2014 Apr 23.

Ischemic cardiac disease is the leading cause of death in the developed world. The inability of the adult mammalian heart to adequately repair itself has motivated stem cell researchers to explore various strategies to regenerate cardiomyocytes after myocardial infarction....

Cite
Chen JX, Plonowska K, Wu SM. Somatic Cell Reprogramming into Cardiovascular Lineages. J Cardiovasc Pharmacol Ther. 2014;19(4):340-349doi: 10.1177/1074248414527641.
Chen, J. X., Plonowska, K., & Wu, S. M. (2014). Somatic Cell Reprogramming into Cardiovascular Lineages. Journal of cardiovascular pharmacology and therapeutics, 19(4), 340-349. https://doi.org/10.1177/1074248414527641
Chen, Jenny X, et al. "Somatic Cell Reprogramming into Cardiovascular Lineages." Journal of cardiovascular pharmacology and therapeutics vol. 19,4 (2014): 340-349. doi: https://doi.org/10.1177/1074248414527641
Chen JX, Plonowska K, Wu SM. Somatic Cell Reprogramming into Cardiovascular Lineages. J Cardiovasc Pharmacol Ther. 2014 Jul;19(4):340-349. doi: 10.1177/1074248414527641. Epub 2014 Apr 23. PMID: 24764131; PMCID: PMC4516712.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries